Back to YC Companies
Algen Biotechnologies
Winter 2020
Active
Using CRISPR to find treatments for cancer and inflammation
17 people View on YC
Algen Biotechnologies at a glance
- Y Combinator batch
- Winter 2020
- Status
- Active
- Industry
- Healthcare
- Team size
- 17 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About Algen Biotechnologies
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR gene-modulation and frontier AI to find drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
Tags:
CRISPR
Biotech
Therapeutics
Drug discovery
AI